Within the actigraphy device market, Sleep Disorders held the largest share in 2025, reflecting the category’s established clinical relevance and routine use in monitoring sleep-wake patterns over extended periods. Demand remains concentrated here because actigraphy devices offer a practical, less resource-intensive option for assessing insomnia, circadian rhythm disruption, and related conditions outside specialized lab settings. That everyday usability helps sustain the segment’s share, especially where providers need longitudinal behavioral sleep data without relying solely on more complex diagnostic workflows.

Chronic Disease Management is emerging as the fastest-growing application in the actigraphy device market as care models increasingly depend on continuous, real-world activity and rest tracking to support long-term patient monitoring. Its momentum is tied to the growing need to observe functional status and daily behavioral patterns in patients managing ongoing conditions, where changes in movement, sleep, and routine can inform care decisions. Compared with narrower diagnostic use cases, this segment is seeing wider adoption because it aligns more directly with broader remote monitoring and ongoing management needs.

End Use Segment Analysis: Healthcare Providers (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)

Healthcare Providers accounted for the largest share of the actigraphy device market in 2025, underpinned by their central role in prescribing, interpreting, and integrating actigraphy data into patient assessment pathways. The segment’s leadership is maintained through the fact that providers remain the primary point of care for sleep evaluation and activity-based monitoring, with established workflows for using device-generated data in clinical decision-making. This institutional adoption continues to anchor market share because healthcare settings provide the oversight, diagnostic context, and continuity needed for effective actigraphy use.

Homecare Settings represent the fastest-growing end-use segment in the actigraphy device market, influenced by rising preference for monitoring patients in their normal living environments rather than only in formal care facilities. Growth is being underpinned by the practical value of capturing everyday sleep and activity patterns with minimal disruption, which makes home-based use especially attractive for longer observation periods. Relative to provider-centered settings, homecare is gaining momentum because it better matches the shift toward decentralized monitoring and ongoing patient management outside traditional clinical environments.